Flow-mediated vasodilation is endothelium dependent. We hypothesized that flow activates a potassium channel on the endothelium, and that activation of this channel leads to the release of the endogenous nitrovasodilator, nitric oxide. To test this hypothesis, rabbit iliac arteries were perfused at varying flow rates, at a constant pressure of 60 mm Hg. Increments in flow induced proportional increases in vessel diameter, which were abolished by L,Nmono-methylarginine (the antagonist of nitric-oxide synthesis). Barium chloride, depolarizing solutions of potassium, verapamil, calcium-free medium, and antagonists of the KCa channel (charybdotoxin, iberiotoxin) also blocked flow-mediated vasodilation. Conversely, responses to other agonists of endothelium-dependent and independent vasodilation were unaffected by charybdotoxin or iberiotoxin. To confirm that flow activated a specific potassium channel to induce the release of nitric oxide, endothelial cells cultured on micro-carrier beads were added to a flow chamber containing a vascular ring without endothelium. Flow-stimulated endothelial cells released a diffusible vasodilator; the degree of vasorelaxation was dependent upon the flow rate. Relaxation was abrogated by barium, tetraethylammonium ion, or charybdotoxin, but was not affected by apamin, glybenclamide, tetrodotoxin, or ouabain. The data suggest that transmission of a hyperpolarizing current from endothelium to the vascular smooth muscle is not necessary for flow-mediated vasodilation. Flow activates a potassium channel (possibly the KCa channel) on the endothelial cell membrane that leads to the release Abstract Flow-mediated vasodilation is endothelium dependent. We hypothesized that flow activates a potassium channel on the endothelium, and that activation of this channel leads to the release of the endogenous nitrovasodilator, nitric oxide. To test this hypothesis, rabbit iliac arteries were perfused at varying flow rates, at a constant pressure of 60 mm Hg. Increments in flow induced proportional increases in vessel diameter, which were abolished by LN-mono-methylarginine (the antagonist of nitric-oxide synthesis). Barium chloride, depolarizing solutions of potassium, verapamil, calcium-free medium, and antagonists of the Kc. channel (charybdotoxin, iberiotoxin) also blocked flow-mediated vasodilation. Conversely, responses to other agonists of endothelium-dependent and independent vasodilation were unaffected by charybdotoxin or iberiotoxin. To confirm that flow activated a specific potassium channel to induce the release of nitric oxide, endothelial cells cultured on microcarrier beads were added to a flow chamber containing a vascular ring without endothelium. Flow-stimulated endothelial cells released a diffusible vasodilator, the degree of vasorelaxation was dependent upon the flow rate. Relaxation was abrogated by barium, tetraethylammonium ion, or charybdotoxin, but was not affected by apamin, glybenclamide, tetrodotoxin, or ouabain.
Introduction
As blood flow increases through a conduit artery, the vessel dilates (1) . This phenomenon is directly dependent upon changes in flow, rather than pressure, and is mediated by a nonneurogenic local mechanism (2) . The mechanism of flowmediated vasodilation is not well understood. Recently a number ofgroups have provided evidence that flow-mediated vasodilation is dependent upon an intact endothelium (34) . These Address correspondence to Dr. John P. Cooke, Division of Cardiovascular Medicine, CVRC, Stanford University School ofMedicine, Stanford, CA 94305.
Receivedforpublication 24 January 1990 and in revisedform 8 July 1991. investigators have proposed that vasodilation is mediated by the endothelium-derived relaxing factor (nitric oxide), first described by Furchgott and Zawadzki (7) . Other investigators have found specific ionic channels within the endothelial cells to be activated by mechanical deformation of the membrane (8, 9) . Oleson et al. proposed that flow-mediated vasodilation may be partly due to activation ofan inwardly rectifying potassium channel within the endothelium; the resulting hyperpolarization is transmitted through gap junctions to the underlying smooth muscle to contribute to the vasodilation (9) .
In a previous investigation, we found that endothelial cells exposed to shear stress released a diffusible vasodilator (10) . This endogenous vasodilator had the characteristics of nitric oxide, in that the vasodilation was blocked by hemoglobin, methylene blue, and L,N-monomethylarginine. To link our observations with those of Oleson et al., we proposed a unifying hypothesis that flow activates a potassium channel on the endothelium, and that activation ofthis channel leads to the release of the endogenous nitrovasodilator, nitric oxide. The present investigation was designed to test this hypothesis.
Methods
Preparation ofblood vessels. New Zealand white female rabbits weighing 2-3 kg were anesthetized with intravenous sodium pentobarbital (30 mg/kg). The thoracic aorta and iliac arteries were excised and the tissue placed in cold physiologic saline solution of the following composition (mM): NaCl, 118.3; KCI, 4.7; CaCl2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 25.0; calcium disodium edetate, 0.026; and glucose, 1 1.1. The vessels were cleaned of adherent connective tissue and the aorta was cut into rings (5 mm in length) for study in the organ and flow chamber experiments (below). Side branches ofthe iliac artery were occluded using electrocautery, and the vessel cut into 15-mm segments for study in the arteriograph (below). In some aortic rings, the endothelium was removed by gentle rubbing with a watchmaker's forceps inserted into the lumen.
Organ chamber studies. To study pharmacological responses in the absence of flow, rings of rabbit thoracic aorta were suspended in organ chambers filled with 25 ml of physiologic saline solution (37°C) aerated with 95% 0J5% CO2. Rings were connected to force transducers (FTO3C; Grass Instrument Co., Quincy, MA) and changes in isometric force were recorded continuously (Grass polygraph 79B). Over a 90-min period the vascular rings were stretched to the optimal point of their length-tension relationship (determined by periodically stimulating the tissue with 10-6 M norepinephrine). Subsequently, in all rings the EC50 (concentration ofdrug inducing a half-maximal response) for norepinephrine was determined by exposing the tissues to increasing concentrations ofnorepinephrine, added to the organ chamber in halflog increments in a cumulative manner. After a maximal response to norepinephrine was obtained, the vascular rings were washed repeatedly with fresh physiologic saline solution until tension returned to the previous baseline value. Tissues were then exposed to antagonists or vehicle controls for 20 min. To study vasodilating agents, rings were then contracted by the EC5o concentration of norepinephrine. After a stable contraction was obtained, the tissue was exposed to cumulative increases in concentration of the vasodilator in half-log increments; relaxations are expressed as a percentage of the response to the EC5, concentration of norepinephrine.
Arteriograph studies. To study the effect of changes in flow upon vessel diameter, iliac arteries were mounted in an arteriograph (Living Systems Instrumentation, Burlington, VT), filled with oxygenated physiologic saline solution at 370C. Both ends ofthe vessel were cannulated by glass capillary tubing for perfusion with oxygenated physiologic saline solution. The proximal cannula was connected to a syringe (driven by a pressure-servo system) that delivered the perfusate at a constant luminal pressure of 60±2 mm Hg. The outflow cannula was connected to a flexible plastic tubing that was threaded through a thumbscrew clamp. The resistance ofthe outflow tubing was varied by adjusting the thumbscrew clamp. This system permitted rapid changes in flow (0-5 ml/min) at constant pressure to be correlated with simultaneous measurement of vessel diameter. Changes in vessel diameter were monitored by a video system consisting ofa Leitz inverted microscope, RCA video camera (RCA Electro-Optics & Devices, Lancaster, PA), and video monitor. Midplane transverse diameters were measured with a caliper accurate to 0.01 mm directly applied to the video screen. Absolute calibration was obtained before each experiment with a micrometer grid placed at the level of the vessel. With this system, highly accurate measurements of vessel diameter are obtained (11) . The images were stored on VHS tape using a Panasonic VHS recorder. Before studying the effects of flow on the vessel, perfusate-containing antagonists or vessel control was instilled intraluminally and incubated with the tissue for 20 min under no-flow conditions. Subsequently the vessel was exposed to 60±2 mm Hg pressure under no-flow conditions, and then contracted by adding norepinephrine (10-' M) or potassium chloride (80 mmol) to the external bath. When the vessel diameter stabilized at a pressure of 60±2 mm Hg, flow was initiated. Flow was measured by collecting the outflow from the distal cannula and weighing it on a Mettler scale. Vessel diameter was measured after 1 min of flow stimulus. For each condition to which the vessel was exposed (i.e., control solution or antagonist), the flow stimulus was repeated two to four times and measurements of vessel diameter and flow rate were averaged. To determine the response to receptor-mediated vasodilators, after contraction to norepinephrine, perfusate containing the vasodilator was instilled intraluminally and incubated with the tissue for 5 min in the absence offlow at a pressure of60±2 mm Hg, and measurements of vessel diameter were repeated.
Microcarrier endothelial cell cultures. Endothelial cells were isolated from bovine aorta using established techniques and were cultured on a microcarrier system ofnegatively charged plastic beads (BiosilonR; Nunc, Roskilde, Denmark) as previously described (12) . Bovine aorta endothelial cells were grown in DME containing 25 M Hepes and 10% FCS. DME was composed of (mM): NaCl, 109; KCI, 5.5; CaCI2, 1.8; MgSO4, 1.7; NaHC13, 51; NaH2PO4, 1.0; Fe(N03).9 H20, 3.6 X 10-3; glucose, 30; sodium pyruvate, 1.0; and phenosulfonphthalein, 4.2 X 10-2. Cells were cultured for 1 wk, placed on microcarrier beads, and then grown to confluence. Before use, the cells (on microcarrier beads) were resuspended in fresh DME without calf serum. Cells were then drawn up and permitted to settle to a packed volume of0.4 ml in a I -ml Eppendorf pipette tip, and transferred to the flow chamber for study.
Flow chamber studies. If flow-mediated vasodilation is largely due to a wave of hyperpolarization spreading from the endothelium to the underlying vascular smooth muscle, intercellular connections (i.e., gap junctions) would be required. Conversely, if flow-mediated vasodilation is largely due to the release of a diffusible factor, intercellular connections would not be necessary. To test the hypothesis that cell contact with the vascular smooth muscle is essential for vasorelaxation by flow-stimulated endothelial cells, a flow chamber was used (10, 13, 14) . This apparatus is a smalljacketed glass chamber (2 cm3 (10-6 M) to the solution in the presence of antagonist or vehicle control. Once the contraction has stabilized, bovine aortic endothelial cells on microcarrier beads (EC) are added to the chamber. Vortical flow is then induced by activation ofthe magnetic stirrer. The flow velocities generated by this system (measured by laser Doppler velocimetry) induce endothelial shear stresses of0.1-0.4 dyn/cm2. This shear stress is well within the range ofvalues attained in conduit vessels in vivo. Under these conditions, endothelial cells release a vasodilator that also inhibits platelet aggregation (10, 13, 14) .
Drugs. The following drugs were used: acetylcholine chloride, apamin, barium chloride, glybenclamide, norepinephrine hydrochloride, ouabain octahydrate, saponin, sodium nitroprusside, tetrodotoxin, verapamil hydrochloride (Sigma Chemical Co., St. Louis, MO), sodium pentobarbital (Abbott Laboratories, North Chicago, IL), L,N-monomethyl-arginine sulphonate (Calbiochem-Behring Corp., San Diego, CA), tetraethylammonium chloride (Kodak Laboratory and Specialty Chemicals, Rochester, NY), and charybdotoxin and iberiotoxin (kindly provided by Dr. Maria Garcia, Merck Sharpe & Dohme Research Laboratories, West Point, PA). Glybenclamide and LN-monomethylarginine were dissolved in 50% ethanol; all other agents were soluble in distilled water or physiological saline solution. In experiments employing L,N-monomethylarginine or glybenclamide, the control vessel was exposed to the same concentration of vehicle. When barium chloride was employed, the physiologic saline solution was modified to increase the solubility ofbarium by replacing KH2PO4 and MgSO4 with equimolar concentrations of KCI and MgCl, respectively.
In experiments employing BaCl, the control vessel was exposed to this modified saline solution. In flow chamber experiments employing ouabain, endothelial cells were separately incubated for 20 min with physiologic saline solution alone, or that containing ouabain (5 X 10-6 M); the cells were then transferred to the flow chamber for study. This was done to avoid the effects of ouabain on smooth muscle tone (15) .
Data analysis. In the organ and flow chamber studies, the tension remaining after exposure to vasodilators is expressed as percent of the initial contraction to norepinephrine. Responses to vasodilators were analyzed by determining the EC.0 (concentration of drug-inducing half-maximal relaxation, expressed as the negative logarithm) and the maximal response (the tension remaining after maximal vasodilation, expressed as a percentage ofthe initial contraction to norepinephrine). All experiments in the flow and organ chambers employing antagonists were performed with simultaneous controls.
In the arteriograph, tissues were exposed to norepinephrine (10-5 M), or in some experiments KCI (8 X 10-2 M). When the vessel diameter stabilized (after [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 
Results
Arteriograph studies. After exposure to norepinephrine (i0-5 M) and at a constant pressure of60±2 mm Hg, flow induced an increase in the diameter of the iliac artery which was directly proportional to the rate of flow (Fig. 1) . Removal of the endothelium abolished the vasodilation to flow as well as that to acetylcholine iO-7 M, but did not affect the response to nitroglycerine (Fig. 2) . The antagonist of arginine metabolism, L,N-monomethylarginine (1O-' M) reversed flow-mediated vasodilation to a vasoconstriction (Fig. 3) . L,N-monomethylarginine did not affect contractions to norepinephrine (Table I) . Flow-mediated vasodilation was also reversed by barium chloride (l0-3 M) and by depolarizing solutions of potassium chloride (8 x 1O-2 M) (Fig. 3) . The abolition of flow-mediated vasodilation was not due to changes in vascular smooth muscle tone, since contractions to norepinephrine were not altered by barium (Table I) . Likewise, when depolarizing solutions ofpotassium chloride were substituted for norepinephrine the contractions induced were not different from those to norepinephrine (Table I) . Nanomolar concentrations ofiberiotoxin or charybdotoxin also reversed flow-mediated vasodilation (Figs. 1 and 3) . Conversely, vasodilation to acetylcholine chloride (l-7 M) and sodium nitroprusside (1I-' M) was preserved in the presence of charybdotoxin 1o-8 M (data not shown). Likewise, iberiotoxin (10-9 M) did not impair vasodilation to acetylcholine chloride, l0-7 M (17.8±4.1 vs. 12.0±2.8% increase in vessel diameter, control vs. experimental group, P = NS). Low concentrations of verapamil (10-9 M, 10-8 M) that did not affect the contraction to norepinephrine (Table I ) also inhibited the flow response (Fig. 4) . The reversal offlow-mediated vasodilation by a higher concentration of verapamil (1 0-7 M) was not due to an inability of the vessel to relax further, since addition of verapamil (l0-5 M) in the absence of flow induced a further increase in the vessel diameter (11.8±4.7%, n = 4). This effect of verapamil was probably due to inhibition of extracellular calcium entry, since removal of calcium from the perfusate also blocked flow-mediated vasodilation (Fig. 5) . Abolition of flowmediated vasodilation by the potassium channel antagonists or by the inhibitor of nitric oxide synthesis was not due to differences in flow rates or changes in vessel response with time (Table I, Fig. 3 bar) had no effect on vascular response. For each condition to which the vessel was exposed, the flow stimulus was repeated two to four times, and measurements of flow rates and vessel diameter averaged for each vessel (see Table I ). *Significantly different from paired control, P = 0.01. **Significantly different from paired control, P < 0.001.
highest concentration of verapamil (10-7 M), the antagonists did not affect vessel diameter before flow, in comparison to vehicle controls (Table I) . Organ chamber studies. To determine whether potassium channel antagonists affect endothelium-dependent or independent relaxations of rabbit thoracic aorta in the absence of flow, responses of vascular rings (with endothelium) were studied in the organ chamber. Sodium nitroprusside induced concentration-dependent relaxations of vascular rings that were unaffected by tetraethyl-ammonium ion, barium, or charybdotoxin (Table II) . Likewise, iberiotoxin (10-9 M) did not affect relaxation to nitroglycerin (Table III) . Contractions to norepinephrine were unaffected by barium or the other antagonists (Tables  II and III) .
Acetylcholine is known to induce relaxations in vitro that are dependent upon the presence of endothelium (7). In the presence oftetraethylammonium ion, relaxations to acetylcholine were observed but the maximum response was slightly decreased (Table II) . Barium ion, charybdotoxin, or verapamil had no effect on the EC50 or maximal response to acetylcholine chloride (Tables II and IV) . Likewise, iberiotoxin (I0-' M) did not affect endothelium-dependent relaxation to acetylcholine chloride, adenosine diphosphate, or calcium ionophore (Table III).
Flow chamber studies. The arteriograph studies suggested that activation of an endothelial potassium channel and the release of nitric oxide were necessary for flow-mediated vasodilation. To determine whether flow-mediated activation of a potassium channel plays a role in the release of nitric oxide, endothelial cells cultured on microcarrier beads were stimulated by flow in the absence or presence of a variety of potassium channel antagonists. Under control conditions, relaxation of the ring occurred, the degree of which was directly related to the endothelial shear stress induced by flow (Fig. 6) ; * Vessel diameter after exposure to norepinephrine (10-s M) at a pressure of 60±2 mm Hg and at a flow rate of 0 ml/min. The exception is where KCI (8 X 10-2 M) was substituted for norepinephrine.
In these experiments vessel diameter after exposure to norepinephrine (control) was not different from that with KCI. * For each condition to which the vessel was exposed, the flow stimulus was repeated two to four times, and measurements of flow rate and vessel diameter averaged. § Significantly different from paired control value (P value in parentheses). (l0-' M), apamin (l0-' M), and ouabain (5 X 10-6 M) had no effect (Table V) .
Discussion
The present study demonstrates that flow induces the endothelium to synthesize and release an endogenous nitrovasodilator. More importantly, this investigation reveals for the first time that the release of this nitric oxide by flow is dependent upon activation ofa potassium channel on the endothelial cell membrane. Barium or depolarizing solutions of potassium inactivate most potassium channels and are also known to inactivate the endothelial potassium channel activated by shear stress (9, 16) . In our investigation, these agents reversed flow-mediated vasodilation to a vasoconstriction, suggesting that a potassium channel is involved in the response. Our additional studies support the hypothesis that the channel involved in the flow response is the calcium-activated potassium (Kc) channel. Tetraethylammonium ion (1 mM) markedly reduces the openstate probability and single-channel conductance of the K<, channel, whereas many other potassium channels (such as the ATP-sensitive inward-rectifier) are insensitive to this concentration oftetra-ethylammonium ion (17, 18) . Charybdotoxin is a potent antagonist of the Kc. channel without any activity against sodium channels, L-or T-type calcium channels, or a variety of other potassium channels (19, 20) . However, it also inhibits the voltage-dependent potassium channel found in lymphocytes; an intermediate conductance calcium-activated channel in Aplysia neurons; and, as expressed in oocytes, the Shaker channel as well as a neuronal A-type channel (20) (21) (22) (23) . Therefore, the observations that tetraethylammonium ion and charybdotoxin block flow-mediated vasodilation suggest that the Kc. channel is involved, but do not entirely rule out a role for other channels.
By contrast, iberiotoxin is highly selective for the Kc. channel and does not inhibit the other charybdotoxin-sensitive potassium channels (24) . In nanomolar concentrations, iberiotoxin blocked flow-mediated vasodilation. As further evidence that the Kc channel is involved, other potassium channel antagonists had no effect on flow-mediated vasodilation. Specifically, glybenclamide (the antagonist of the ATP-associated potassium channel), apamin (the antagonist of the low conductance calcium-activated potassium channel), tetrodotoxin (the sodium channel antagonist which also blocks the sodium-activated potassium channel), and ouabain (the antagonist of sodium, potassium, ATPase) had no effect. * Expressed as the ECo (concentration of drug, in -log M, inducing a half-maximal response) and as the maximal response (the tension remaining after maximal vasodilation, expressed as a percentage of the initial contraction to norepinephrine). Where the maximal response was depressed, an ECso was not calculated (37) . t Isometric force (measured in grams) generated in response to the EC50 concentration of norepinephrine. I Significantly less relaxation in comparison to control, P = 0.05. Abbreviations: TEA, tetraethylammonium ion (10-' M).
nation for these results is that the high conductance calciumactivated potassium channel is involved in the flow response. Consistent with this interpretation of the data is the observation that verapamil also abolished the flow response, at concentrations that did not affect other endothelium-dependent responses. Sustained activity of the Kc. channel is known to be dependent upon extracellular calcium (25, 26) ; thus a calcium entry antagonist would be expected to interfere with the flow response if the Kc. channel plays an important role. This dependency upon extracellular calcium was confirmed by demonstrating that calcium-free perfusate did not elicit a flow-mediated vasodilation.
Charybdotoxin (10-1 M) did induce a contraction of the iliac artery, probably due to antagonism of Kc. channels present on vascular smooth muscle (19, 24, 27) . Despite this elevation ofbasal tone, relaxations to sodium nitroprusside (an endothelium-independent vasodilator) were preserved. Therefore, flow-mediated vasodilation and that exposure of the vessel to methylene blue or eicosatetraenoic acid (agents known to interfere with the action of nitric oxide) also inhibits flow-mediated relaxation (3) (4) (5) (6) 30) . Although prostacyclin is also released by increased flow (31), we have previously demonstrated that aspirin or indomethacin do not inhibit the effects of flowstimulated endothelial cells on platelet or vascular reactivity (10, 13, 14) . Our findings are supported by the previous observation that the perfused canine femoral artery releases a nitric oxide as well as the prostacyclin metabolite, 6-keto-prostaglandin alpha, (32) . However, when release of the prostanoid is reduced to negligible levels in the presence of indomethacin, the relaxing activity of the perfusate is unaffected. The present investigation and our previous studies strongly support the hypothesis that nitric oxide (33) or a similar endogenous nitrovasodilator (34) is the major effector of flow-mediated vasodilation. In this study the antagonist of arginine metabolism, L,N-monomethylarginine, abolishedthis phenomenon. In a previous study, we found that endothelial cells cultured on microcarrier beads released a labile vasodilator when stimulated by flow. The action ofthis agent was antagonized by methylene blue, hemoglobin, or L,N-monomethylarginine (10). Flow-stimulated endothelial cells also inhibited platelet aggregation; this effect was associated with an increase in platelet cyclic GMP and was attenuated by methylene blue (13, 14) . These studies support a major role for an endogenous nitrovasodilator in the flow phenomenon, but do not exclude participation of the hyperpolarizing current, or other endotheliumderived factors, i.e., the diffusible hyperpolarizing factor (35, 36) . In addition to endogenous vasodilators, an endotheliumderived contractile factor also may be released by flow, since inhibitors of nitric oxide or potassium channel activity generally unmasked a vasoconstriction with flow (present investigation, ref. 10).
Other investigators have proposed that flow may have other effects on the endothelial cell membrane that could lead to vasodilation. Measurements of cell membrane potential reveal that membrane stretch (induced by negative pressure applied to the membrane by a microelectrode) induces depolarization of the cell due to opening of a cationic channel (8) . However, this channel is not selective, allowing entry ofcalcium, sodium, potassium, and cesium. Oleson et al. measured membrane potential in endothelial cells lining a glass capillary tube as a function of rates of fluid flow through the lumen. The magnitude of an inwardly rectifying potassium current varied directly and temporally with the rates offlow and was abolished by millimolar concentrations of barium. These investigators proposed that the hyperpolarization of the endothelial cell induced by this potassium current could be transmitted by gap junctions to the underlying smooth muscle, resulting in vasodilation (9) .
Our investigation reveals that gap junctions between the endothelial cell and vascular smooth muscle are not necessary for flow-mediated vasodilation. An endogenous nitrovasodilator, rather than a wave of hyperpolarization, appears to be primarily responsible for flow-mediated vasodilation. Our data also suggest that the release of nitric oxide by flow is dependent upon the activation ofan endothelial potassium channel, possibly the high conductance calcium-activated potassium channel. We hypothesize that this potassium channel acts as the transducer of the flow stimulus, whereas nitric oxide is the effector of the vasodilation.
